Research
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Latest stories
Individualized Medicine
February 25, 2025
Cardiovascular
February 24, 2025
Cardiovascular
February 12, 2025
Research
February 12, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community